Brand

Merck's Heller on how to get more women into the C-suite

Merck's Heller on how to get more women into the C-suite

By

Bridgette Heller, Merck EVP and president of its consumer care division, adjured life-sci managers to enable women to unleash the full power of their knowledge and ideas to drive growth in the business.

Docs cozy up to brands that bring unique benefits, thought-leader backing

Docs cozy up to brands that bring unique benefits, thought-leader backing

By

Physician trust in pharmaceutical brands is driven by an emotional connection as well as functional attributes and perceptions of the manufacturer, said Harris Interactive, which found Advair, Spiriva and Mirena to be tops in their categories with doctors.

Hologic, seeking rights to Makena, trades barbs with KV

By

Hologic alleges KV has botched the marketing and wants rights to the drug. KV disagrees.

Herceptin treatment time scrutinized by researchers

By

A government-funded study looks at whether patients with breast cancer really need 12 months of the treatment.

Copaxone sales likely to top out this year, Teva exec says

By

Sales of Teva's MS blockbuster Copaxone are likely to peak this year before giving way as more therapeutic options become available, a Teva exec says.

Endo rebrands to move beyond roots in pain drugs

Endo rebrands to move beyond roots in pain drugs

By

Endo is restructuring, bringing its four operating units under the same corporate roof and rebranding to reflect its diversification out of its origins in pain and urology drugs.

FDA gives guidance on brand, generic names in ads

By

The FDA issued guidance clarifying narrow questions of scientific or generic name placement in ads and labeling in different media, including electronic media.

As GSK jettisons consumer brands, smaller marketer sees boon

As GSK jettisons consumer brands, smaller marketer sees boon

By

GlaxoSmithKline divested North American OTC drugs worth about $200 million in sales, a portfolio that seemed like a good strategic fit for buyer Prestige Brands Holdings.

As brand revenue shrinks, so does brand promotion

By

Branded drug sales declined 0.7% to $229 billion last year, according to IMS Health, and that's having an impact on promotional spend.

Viagra, Nexium and Chantix are Mensa-worthy brands, says digital IQ study

Viagra, Nexium and Chantix are Mensa-worthy brands, says digital IQ study

By

Marketers working on Pfizer brands Viagra and Chantix, and AstraZeneca's Nexium, can pat themselves on the back, since they all scored in the "genius" percentile based on digital marketing competency, according to the L2 Digital IQ Index.

E-samples hijack search, study asserts

E-samples hijack search, study asserts

By

Many big pharma firms are running e-samples, a form of marketing which researchers say capitalizes on patients seeking health information and may affect prescribers' preference for brands over generics.

UCB turns Crohn's patients into brand advocates

UCB turns Crohn's patients into brand advocates

By

UCB launched a multifaceted campaign for its Cimzia injectable, calling on patients and doctors to publicly educate others about Crohn's disease and treatment.

Last chance to grab glory

Last chance to grab glory

If you still haven't entered the MM&M Awards 2009, then you'd better move fast--today (June 5) is the final deadline for submissions.

Abbott, AZ extend co-promotion to Trilipix

Abbott, AZ extend co-promotion to Trilipix

By

AstraZeneca will help Abbott reach more physicians with its Trilipix (fenofibric acid) drug, a cholesterol product approved by FDA last December. The companies also filed an NDA for Certriad, a Trilipix/Crestor combination drug.

Gelnique ads swap embarrassment for empowerment

Gelnique ads swap embarrassment for empowerment

By

Watson launched a campaign today for its overactive bladder product Gelnique - the first topical gel indicated for the disorder - featuring younger, active women.

Worldwide, consumers prefer generics, says study

By

Consumers worldwide overwhelmingly prefer medicines that have been around a long time to the latest treatments, and over half prefer generics to branded drugs given the choice, according to a DDB Health survey.

GSK pairs Wynonna Judd album with Alli

By

Consumers purchasing GSK's weight loss drug Alli will receive a free copy of Wynonna Judd's new album "Sing," beginning in March.

McCann launches experiential marketing shop

By

McCann Worldgroup is launching a health and wellness experiential marketing practice under the umbrella of its Momentum network.

Lantus site tops in consumer satisfaction: study

By

The product site for Sanofi-Aventis's insulin injection Lantus received the highest mark in terms of consumer satisfaction, according to a Manhattan Research study.

Pfizer taps McGarryBowen on Chantix, snubs McCann

By

Pfizer passed Chantix creative work to McGarryBowen, ending McCann HumanCare's contract on the smoking cessation drug, agency sources confirmed.

Lilly enters CIA as part of $1.4 billion settlement

By

As part of its $1.415 billion settlement for off-label marketing of Zyprexa, Eli Lilly & Co. will enter a Corporate Integrity Agreement with the HHS Office of Inspector General.

TBWA wins three global Merck brands

By

Merck KGaA has tapped TBWA on three of its consumer healthcare brands: Nasivin, Femibion and Flexagil.

New Lipitor ad features testimonial from heart attack survivor

New Lipitor ad features testimonial from heart attack survivor

By

Pfizer resumes DTC advertising for Lipitor, without Robert Jarvik.

Manhattan Research names top product sites for docs

By

A new study identifies the top 10 product sites visited by primary care physicians.

Vioxx trial described as marketing stunt

Vioxx trial described as marketing stunt

By

Researches involved in the litigation against Vioxx claim the product's ADVANTAGE trials were based on marketing objectives rather than scientific rigor.

Advair superior to Singulair for asthma and allergies: study

By

Advair outperformed Singulair in patients suffering from asthma and seasonal allergies, according to a study conducted by the National Jewish Medical Research Center.

Sudler & Hennessey named global AOR for developmental arthritis med

By

Sudler & Hennessey (S&H) has been selected by AstraZeneca as the global agency partner of record for the developmental arthritis treatment PN400.

Crestor ads take aim at Vytorin, touting atherosclerosis claim

Crestor ads take aim at Vytorin, touting atherosclerosis claim

By

AstraZeneca is going for the jugular - or rather, the carotid - with new ads emphasizing Crestor's effectiveness at slowing the progression of atherosclerosis.

Blueprint for Branding Devices

David Paragamian emphasizes the importance of building master brands and exploring promotional channels

Nexium could face early generic challenge, say analysts

By

AstraZeneca's Nexium could face generic competition much sooner than expected, and would-be investors should be wary, said brokerage firm Sanford C. Bernstein in an analyst note.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.